April 15, 2026 | Press Release NEW Announcement of Launch in Japan of RAVICTI® Oral Liquid 1.1 g/mL March 24, 2026 | Press Release NEW OrphanPacific Obtains Marketing Approval in Japan for Leniolisib (Joenja®) for the Treatment of APDS for adults and pediatric patients 4 years of age and older
March 24, 2026 | Press Release NEW OrphanPacific Obtains Marketing Approval in Japan for Leniolisib (Joenja®) for the Treatment of APDS for adults and pediatric patients 4 years of age and older
